Literature DB >> 9768907

Dupuytren's disease and frozen shoulder induced by treatment with a matrix metalloproteinase inhibitor.

J W Hutchinson1, G M Tierney, S L Parsons, T R Davis.   

Abstract

In a series of 12 patients with inoperable gastric carcinoma who had treatment with a synthetic matrix metalloproteinase inhibitor (Marimastat) for more than one month, six developed a frozen shoulder or a condition resembling Dupuytren's disease. This suggests that the matrix metalloproteinases, a family of naturally occurring proteinases, may be involved in the pathogenesis of these two conditions. Our observation opens avenues for further research which could lead to local or systemic therapeutic interventions for frozen shoulder and Dupuytren's disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9768907     DOI: 10.1302/0301-620x.80b5.8464

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  41 in total

1.  Selective matrix metalloproteinase inhibition increases breaking strength and reduces anastomotic leakage in experimentally obstructed colon.

Authors:  Peter-Martin Krarup; Mikkel Eld; Lars Nannestad Jorgensen; Mark Berner Hansen; Magnus S Ågren
Journal:  Int J Colorectal Dis       Date:  2017-07-17       Impact factor: 2.571

2.  High rate of joint capsule matrix turnover in chronic human elbow contractures.

Authors:  Kevin A Hildebrand; Mei Zhang; David A Hart
Journal:  Clin Orthop Relat Res       Date:  2005-10       Impact factor: 4.176

Review 3.  Frozen shoulder: A systematic review of therapeutic options.

Authors:  Harpal Singh Uppal; Jonathan Peter Evans; Christopher Smith
Journal:  World J Orthop       Date:  2015-03-18

Review 4.  [Primary (idiopathic) shoulder stiffness : Definition, disease progression, epidemiology and etiology].

Authors:  Jonas Pogorzelski; Andreas B Imhoff; Hannes Degenhardt; Sebastian Siebenlist
Journal:  Unfallchirurg       Date:  2019-12       Impact factor: 1.000

5.  Expression and inhibition of matrix metalloproteinase (MMP)-8, MMP-9 and MMP-12 in early colonic anastomotic repair.

Authors:  Peter-Martin Krarup; Mikkel Eld; Katja Heinemeier; Lars Nannestad Jorgensen; Mark Berner Hansen; Magnus S Ågren
Journal:  Int J Colorectal Dis       Date:  2013-04-26       Impact factor: 2.571

6.  Chondrocyte phenotype and ectopic ossification in collagenase-induced tendon degeneration.

Authors:  Pauline Po-yee Lui; Sai-chuen Fu; Lai-shan Chan; Leung-kim Hung; Kai-ming Chan
Journal:  J Histochem Cytochem       Date:  2008-09-29       Impact factor: 2.479

7.  Molecular mechanisms and treatment strategies for Dupuytren's disease.

Authors:  David B O'Gorman; Linda Vi; Bing Siang Gan
Journal:  Ther Clin Risk Manag       Date:  2010-09-07       Impact factor: 2.423

Review 8.  Matrix metalloproteinase inhibitor development and the remodeling of drug discovery.

Authors:  J Thomas Peterson
Journal:  Heart Fail Rev       Date:  2004-01       Impact factor: 4.214

9.  Human articular chondrocytes express 15-lipoxygenase-1 and -2: potential role in osteoarthritis.

Authors:  Nadir Chabane; Nadia Zayed; Mohamed Benderdour; Johanne Martel-Pelletier; Jean-Pierre Pelletier; Nicolas Duval; Hassan Fahmi
Journal:  Arthritis Res Ther       Date:  2009-03-18       Impact factor: 5.156

Review 10.  Metalloproteinases and their inhibitors-diagnostic and therapeutic opportunities in orthopedics.

Authors:  Björn Pasternak; Per Aspenberg
Journal:  Acta Orthop       Date:  2009-12       Impact factor: 3.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.